Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return

Bulletin Express
02/02

Sihuan Pharmaceutical Holdings Group Ltd. (00460) reported that, as of January 31, 2026, the authorized share capital remains at 100,000,000,000 ordinary shares with a par value of HKD 0.01 each, totaling HKD 1,000,000,000. There were no changes from the previous month.

The number of issued shares (excluding treasury shares) remained at 9,145,988,206, and the number of treasury shares stayed at 184,011,000, with no movements during the period. The company confirmed compliance with the applicable public float requirement.

Regarding share options, 60,586,000 options under an exercise price of HKD 0.972 and 7,500,000 options under an exercise price of HKD 2.22 remained outstanding. No new shares were issued or transferred out of treasury shares as a result of the exercise of options during January 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10